Pharmaceutical care in an inpatient pediatric hematopoietic stem cell transplant service

Journal of Oncology Pharmacy Practice

Volumn 14, Issue 3, 2008, Pages 147-152

  Prot Labarthe, Sonia ^a   Therrien, Roxane ^a   Demanche, Colette ^a   Larocque, Diane ^a   Bussières, Jean François ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Bone marrow transplant; Clinical pharmacy; Documentation; Hematopoietic stem cell transplant; Inpatient; Pharmaceutical care; Pharmacist intervention

Indexed keywords

BUSULFAN; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FLUDARABINE; MAGNESIUM; MELPHALAN; ONDANSETRON; THYMOCYTE ANTIBODY; TOBRAMYCIN; VANCOMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG MONITORING; EWING SARCOMA; FEMALE; HEALTH SERVICE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HOSPITAL PATIENT; HUMAN; LEUKEMIA; MALE; MEDICAL DOCUMENTATION; PEDIATRICS; PHARMACEUTICAL CARE; PHARMACIST ATTITUDE; PRIORITY JOURNAL; WHOLE BODY RADIATION; DRUG THERAPY; HOSPITAL PHARMACY; PATIENT CARE PLANNING; PHARMACIST; PHARMACY;

ADOLESCENT; CHILD; DRUG THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INPATIENTS; MALE; PATIENT CARE PLANNING; PHARMACEUTICAL SERVICES; PHARMACISTS; PHARMACY SERVICE, HOSPITAL;

EID: 58249089434     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155208093929     Document Type: Article

References (23)

1. Holland RW, Nimmo CM Transitions, part 1: Beyond pharmaceutical care. Am J Health Syst Pharm 1999; 56(17): 1758-64.
2. Hepler CD, Strand LM Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47(3): 533-43.
3. Broadfield L. Survey of Canadian oncology pharmacy services-the emergence of a specialty. Can J Hosp Pharm 1991; 44(3): 111-20.
4. Bremberg ER, Hising C., Nylen U., Ehrsson H., Eksborg S. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital. J Oncol Pharm Pract 2006; 12(2): 75-81.
5. Shah S., Dowell J., Greene S. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting. Ann Pharmacother 2006; 40(9): 1527-33.
6. Waddell JA, Solimando Jr, DA, Strickland WR, Smith BD, Wray MK Pharmacy staff interventions in a medical center hematology-oncology service. J Am Pharm Assoc (Wash) 1998; 38(4): 451-56.
7. Bourret JA, Demers RF, Wordell D., Irani M., Baker J., Evangelista C. Medication use review process and information systems utilized for oncology chemotherapy quality improvement. Pharm Pract Manag Q 1996; 16(1): 1-17.
8. Pon D. Service plans and clinical interventions targeted by the oncology pharmacist. Pharm Pract Manag Q 1996; 16(1): 18-30.
9. Rapport annuel 2005-2006. Pharmacies hospitalières canadiennes. Éthique en pharmacie hospitalière. 2007. (Accessed 15 January 2008, at www.lillyhospitalsurvey.ca).
10. Woloschuk DM, Nazeravich DR, Gray LJ, Larter JM Establishment of a bone marrow transplant satellite pharmacy. Can J Hosp Pharm 1993; 46(1): 5-11.
11. King RS, Wordell CJ, Haupt BA Pharmaceutical services and inpatient drug costs in bone marrow transplantation. Am J Hosp Pharm 1994; 51(10): 1339-42.
12. Wu HT, Graff LR, Yuen CW Clinical pharmacy in an inpatient leukemia and bone marrow transplant service. Am J Health Syst Pharm 2005; 62(7): 744-47.
13. Allenet B., Bedouch P., Rose FX et al. Validation of an instrument for the documentation of clinical pharmacists' interventions. Pharm World Sci 2006; 28(4): 181-88.
14. Prot-Labarthe S., Pelletier E., Winterfeld U. et al. Comparison of pain management in paediatric surgical patients in two hospitals in France and Canada. Pharm World Sci 2008; 30(3): 251-257.
15. Prot-Labarthe S., Bussieres JF, Brion F., Bourdon O. Comparison of hospital pharmacy practice in France and Canada: Can different practice perspectives complement each other? Pharm World Sci 2007; 29(5): 526-33.
16. Bussieres JF, Theoret Y., Prot-Labarthe S., Larocque D. Program to monitor surface contamination by methotrexate in a hematology-oncology satellite pharmacy. Am J Health Syst Pharm 2007; 64(5): 531-35.
17. Bussières J., Roy P., Lebel D., Binette M., Cambar J., Colombel C. [Pharmaceutical practices in France and in Quebec and exchange prospects] Pratique pharmaceutique en France et au Québec: perspectives d'échanges? J Pharm Clin 2002; 21(1): 9-13.
18. Prot-Labarthe S., Lavoie A., Bourdon O. et al. [Pilot study about pharmaceutical care implantation in a general paediatric unit in a French hospital. France-Quebec collaboration and comparison]. Arch Pediatr 2007; 14(4): 345-53.
19. Holcombe BJ Oncology pharmacy as a specialty. Am J Health Syst Pharm 1996; 53(7): 734.
20. Robelet A., Therrien R., Bussières J., Lebel D., Larocque D. Evaluation of a pharmaceutical care model in a Pediatric Hematology/ Oncology Unit (under review). Journal of Pediatric Pharmacology and Therapeutics 2008.
21. Boardman H., Fitzpatrick R. Self reported clinical pharmacist interventions under-estimate their input to patient care. Pharm World Sci 2001; 23(2): 55-59.
22. LeRoy ML, Pruemer J. Impact of an oncology pharmacy residency training program on quality improvement initiatives in an oncology center. Pharm Pract Manag Q 1996; 16(1): 59-65.
23. Prot-Labarthe S., Therrien R., Champagne MA, Duval M., Joubert C. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease. Bone Marrow Transplant 2007; 40(3): 295-96.